NIH-funded research R01 grant

Using machine learning to find sleep apnea patients at risk for heart disease

Official title: Application of Machine Learning to Identify Obstructive Sleep Apnea Subgroups at Risk for Atherosclerosis Progression and Cardiovascular Disease Events (OSA-GRANDE)

Funded at Icahn School of Medicine at Mount Sinai · NIH-11041046 · Data updated 2026-11-12

This study is looking at how advanced computer technology can help find people with obstructive sleep apnea who might be more likely to develop heart problems, so that doctors can tailor treatments to each person's needs and improve their care.

More Cardiovascular Disease research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionIcahn School of Medicine at Mount Sinai
NIH-funded
Lab location1 site (New York, United States)
Project startMarch 1, 2024
Project endDecember 31, 2027
Funding year2025
Award (this year)$669,381
NIH project number5R01HL168897-02
Project IDNIH-11041046 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include adults diagnosed with obstructive sleep apnea who are at risk for cardiovascular disease.

Less likely to help

Patients without obstructive sleep apnea or those who do not have cardiovascular disease risk factors may not benefit from this research.

What this research studies

This research investigates how machine learning can analyze various data sources to identify patients with obstructive sleep apnea (OSA) who are at higher risk for developing cardiovascular disease (CVD). By examining multimodal data beyond traditional sleep studies, the project aims to create predictive tools that can forecast CVD events and understand how different patients respond to CPAP treatment. The goal is to enhance patient care by personalizing treatment strategies based on individual risk profiles. Participants will be monitored and their health records will be used to validate the effectiveness of these predictive models.

Why it matters

Potential benefit: If successful, this research could lead to better-targeted treatments for sleep apnea patients, potentially reducing their risk of heart disease.

How similar studies have gone: Previous research has shown promise in using machine learning for health predictions, suggesting that this approach could yield significant insights in the context of sleep apnea and cardiovascular risk.

Where this research is happening

  • Icahn School of Medicine at Mount Sinai
    New York, United States
    Active

Researchers

  • Principal investigator: Shah, Neomi a — Icahn School of Medicine at Mount Sinai
  • Study coordinator: Shah, Neomi a

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.